Essure® is indicated for women who desire permanent birth control (female sterilization) by bilateral occlusion of the fallopian tubes. WARNING: Some patients implanted with the Essure System for Permanent Birth Control have experienced and/or reported adverse events, including perforation of the uterus and/or fallopian tubes, identification of inserts in the abdominal or pelvic cavity, persistent pain, and suspected allergic or hypersensitivity reactions. If the device needs to be removed to address such an adverse event, a surgical procedure will be required. This information should be shared with patients considering sterilization with the Essure System for Permanent Birth Control during discussion of the benefits and risks of the device. Caution: Federal law restricts this device to sale by or on the order of a physician. Device to be used only by physicians who are knowledgeable hysteroscopists; have read and understood the Instructions for Use and Physician Training Manual; and have successfully completed the Essure training program, including preceptoring in placement until competency is established, typically 5 cases. The sale and distribution of this device are restricted to users and/or user facilities that provide information to patients about the risks and benefits of this device in the form and manner specified in the approved labeling provided by Bayer. Essure is contraindicated in patients who are uncertain about ending fertility, can have only one insert placed (including contralateral proximal tubal occlusion or suspected unicornuate uterus), have a known abnormal uterine cavity that makes visualization of the tubal ostia impossible, and/or abnormal tubal anatomy or previous tubal ligation (including failed ligation), are pregnant or suspect pregnancy, delivered or terminated a pregnancy less than 6 weeks prior to the Essure procedure, have an active upper or lower genital tract infection, have unexplained vaginal bleeding, have a gynecological malignancy, or have a known allergy to contrast ...
| Website | http://www.essure.com |
| Revenue | $5.9 million |
| Employees | View employees |
| Address | 331 E Evelyn Ave, Mountain View, California 94041, US |
| Phone | +1 650-962-4000 |
| Industry | Insurance |
| Competitors | Johnson & Johnson, AbbVie, Merck & Co., Inc., Pfizer, Bayer, AstraZeneca, Bristol Myers Squibb, Teva Pharmaceuticals, Hologic, Inc., CooperSurgical +35 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Essure employee's phone or email?
The Essure annual revenue was $5.9 million in 2026.
Essure is based in Mountain View, California.
The NAICS codes for Essure are [325, 32].
The SIC codes for Essure are [283, 28].